Registered entities
Valink Therapeutics Inc
Reg. No. 4383316United States
LILIUMX LTD.
Reg. No. 13077801United Kingdom
Investor mix
13 investors on record; lead investors include Redalpine.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 92% |
| Accelerator & incubator | 1 | 8% |